FDA efficiency for approval process of COVID-19 therapeutics

Review Article (Web of Science)

• cited authors: Cassidy, Christine; Dever, Danielle; Stanbery, Laura; Edelman, Gerald; Dworkin, Lance; Nemunaitis, John
• authors: Dworkin, Lance D
• publication date: December 1, 2020
• webpage: Web of Science
• published in: INFECTIOUS AGENTS AND CANCER Journal
• category: IMMUNOLOGY Category

keywords

• COVID-19
• Drug development
• FDA
• SARS-CoV-2

• volume: 15
• issue: 1